UCare enhances diabetes pharmacy benefit with insulin cap


This week, UCare, an independent, nonprofit health plan, filed its final 2020 MNsure Individual and Family plan benefits and rates with the Minnesota Department of Commerce. The filing provides members who have diabetes with financial relief through a $25 cap on monthly insulin costs, effective Jan. 1, 2020. Rounding out UCare’s suite of diabetes services, the cap applies to all insulin covered by the members’ plan and is available with UCare’s current plans and new HSA plans.

“When we designed our 2020 Individual and Family plans, we gave considerable attention to helping our members with diabetes afford insulin,” said Mark Traynor, President and Chief Executive Officer. “As the health plan with the largest enrollment through MNsure, we felt a special responsibility to be part of a solution to this important public health issue.”

The pharmacy benefit completes UCare’s full slate of diabetes programs supporting optimal health for our members living with diabetes. A healthy lifestyle is key to controlling blood sugar levels when you live with diabetes. UCare supports healthy lifestyles through such offerings as:

The cost relief is made possible by recent IRS guidance allowing coverage for insulin benefits outside of a deductible for certain high-deductible health plans. UCare partnered with our pharmacy benefit manager and insulin manufacturers on a plan to bring down the monthly cost of insulin for members.